AstraZeneca Acknowledges Blood Clotting Risk - Concerns for Covishield Vaccine Recipients in India?
Study Glows Study Glows
1.95M subscribers
18,525 views
0

 Published On May 1, 2024

Join Prashant Mavani on Study Glows as we delve into the latest developments surrounding AstraZeneca's acknowledgment of blood clotting risks associated with its vaccine. Explore the implications for Covishield recipients in India and gain insights into the ongoing discussions and concerns surrounding vaccine safety.

CRIME AFFAIRS LINK 🔴
   / @crimeworld16  

CONNECT WITH US 📱
Telegram PDF Link ►
https://t.me/study_glows/



Siddhant Agnihotri on Facebook   / siddhant.agn.  .
Siddhant Agnihotri on Twitter https://twitter.com/siddhantagnih12?l...
Siddhant Agnihotri on Facebook   / siddhant.agn.  .
Rashi Singhal on Facebook   / urmi.singhal  
Rashi Singhal Study Glows:   / rashi-singha.  .

show more

Share/Embed